Federal Appellate Court Distinguishes Certain Drug Rebates From Unlawful Kickbacks
Regeneron Pharmaceuticals, Inc. manufactures Eylea. Eylea is one of just a few drugs approved by the Food and Drug Administration (FDA) for treating an ophthalmological condition called neovascular age-related macular degeneration, also known as wet AMD. Eylea is a “buy and bill” drug un[...]